Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | ABCB11 CL E G H | 8647 | 42 | OMIM:601847 | Cholestasis, progressive familial intrahepatic 2 | . | | | 146 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | ACOX2 CL E G H | 8309 | 120 | OMIM:617308 | Bile acid synthesis defect, congenital, 6 | | | | 2 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | AKR1D1 CL E G H | 6718 | 388 | OMIM:235555 | Bile acid synthesis defect, congenital, 2 | | | | 62 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | AMACR CL E G H | 23600 | 451 | OMIM:214950 | Bile acid synthesis defect, congenital, 4 | . | | | 44 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | | | | 49 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | APOB CL E G H | 338 | 603 | OMIM:615558 | Hypobetalipoproteinemia, familial, 1 | | | | 356 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:211600 | Cholestasis, progressive familial intrahepatic 1 | . | | | 144 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CCDC47 CL E G H | 57003 | 24856 | OMIM:618268 | Trichohepatoneurodevelopmental syndrome | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CEACAM3 CL E G H | 1084 | 1815 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CEACAM6 CL E G H | 4680 | 1818 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CFTR CL E G H | 1080 | 1884 | ORPHA:586 | Cystic fibrosis | | | | 1371 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CFTR CL E G H | 1080 | 1884 | OMIM:219700 | Cystic fibrosis | | | | 1371 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CFTR CL E G H | 1080 | 1884 | OMIM:167800 | Pancreatitis, hereditary | | | | 1371 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CLCA4 CL E G H | 22802 | 2018 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CLMP CL E G H | 79827 | 24039 | OMIM:615237 | Congenital short bowel syndrome | | | | 7 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | COX4I2 CL E G H | 84701 | 16232 | OMIM:612714 | Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarialhyperostosis | | | | 13 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CTRC CL E G H | 11330 | 2523 | OMIM:167800 | Pancreatitis, hereditary | | | | 39 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CYP7B1 CL E G H | 9420 | 2652 | OMIM:613812 | Bile acid synthesis defect, congenital, 3 | | | | 57 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | CYP7B1 CL E G H | 9420 | 2652 | ORPHA:79302 | Congenital bile acid synthesis defect type 3 | | | | 57 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | DCTN4 CL E G H | 51164 | 15518 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | DNAJC21 CL E G H | 134218 | 27030 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040281 - Very frequent | | | 5 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | DNAJC21 CL E G H | 134218 | 27030 | OMIM:260400 | Shwachman-Diamond syndrome 1 | | | | 5 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040282 - Frequent | | | 4 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | EDNRA CL E G H | 1909 | 3179 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | EFL1 CL E G H | 79631 | 25789 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040281 - Very frequent | | | 1 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | EFL1 CL E G H | 79631 | 25789 | OMIM:617941 | Shwachman-Diamond syndrome 2 | | | | 1 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | EPCAM CL E G H | 4072 | 11529 | ORPHA:92050 | Congenital tufting enteropathy | | | | 170 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | FCGR2A CL E G H | 2212 | 3616 | OMIM:219700 | Cystic fibrosis | | | | 6 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | GCLC CL E G H | 2729 | 4311 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | GSTM3 CL E G H | 2947 | 4635 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | HFE CL E G H | 3077 | 4886 | ORPHA:586 | Cystic fibrosis | | | | 38 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | HLA-DQA1 CL E G H | 3117 | 4942 | OMIM:212750 | Celiac disease, susceptibility to, 1 | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:212750 | Celiac disease, susceptibility to, 1 | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | HMOX1 CL E G H | 3162 | 5013 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | HSD3B7 CL E G H | 80270 | 18324 | OMIM:607765 | Bile acid synthesis defect, congenital, 1 | . | | | 26 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | KCNN4 CL E G H | 3783 | 6293 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | | | | 70 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | LIPA CL E G H | 3988 | 6617 | OMIM:278000 | Lysosomal acid lipase deficiency | | | | 73 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | LIPA CL E G H | 3988 | 6617 | ORPHA:75233 | Wolman disease | | | | 73 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | MIF CL E G H | 4282 | 7097 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | MPI CL E G H | 4351 | 7216 | OMIM:602579 | Congenital disorder of glycosylation, type Ib | | | | 51 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | MTTP CL E G H | 4547 | 7467 | ORPHA:14 | Abetalipoproteinemia | HP:0040281 - Very frequent | | | 81 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | MTTP CL E G H | 4547 | 7467 | OMIM:200100 | ABETALIPOPROTEINEMIA | . | | | 81 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PERCC1 CL E G H | 105371045 | 52293 | ORPHA:92050 | Congenital tufting enteropathy | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PEX12 CL E G H | 5193 | 8854 | OMIM:266510 | Peroxisome biogenesis disorder 3B | | | | 65 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040282 - Frequent | | | 563 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PMM2 CL E G H | 5373 | 9115 | OMIM:212065 | Congenital disorder of glycosylation, type Ia | | | | 150 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PNLIP CL E G H | 5406 | 9155 | OMIM:614338 | Pancreatic lipase deficiency | . | | | 2 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PRSS1 CL E G H | 5644 | 9475 | OMIM:167800 | Pancreatitis, hereditary | | | | 51 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PRSS2 CL E G H | 5645 | 9483 | OMIM:167800 | Pancreatitis, hereditary | | | | 1 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PTF1A CL E G H | 256297 | 23734 | OMIM:615935 | Pancreatic agenesis 2 | | | | 22 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | PTRH2 CL E G H | 51651 | 24265 | OMIM:616263 | Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset | | | | 6 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SAR1B CL E G H | 51128 | 10535 | OMIM:246700 | Chylomicron retention disease | | | | 8 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SAR1B CL E G H | 51128 | 10535 | ORPHA:71 | Chylomicron retention disease | HP:0040281 - Very frequent | | | 8 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SBDS CL E G H | 51119 | 19440 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040281 - Very frequent | | | 26 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SBDS CL E G H | 51119 | 19440 | OMIM:260400 | Shwachman-Diamond syndrome 1 | | | | 26 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SERPINA1 CL E G H | 5265 | 8941 | ORPHA:586 | Cystic fibrosis | | | | 131 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SHPK CL E G H | 23729 | 1492 | ORPHA:440713 | Isolated sedoheptulokinase deficiency | | | | 2 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SLC10A2 CL E G H | 6555 | 10906 | OMIM:613291 | Bile acid malabsorption, primary | | | | 6 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SLC11A1 CL E G H | 6556 | 10907 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SLC26A9 CL E G H | 115019 | 14469 | ORPHA:586 | Cystic fibrosis | | | | 5 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SLC6A14 CL E G H | 11254 | 11047 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SLC7A7 CL E G H | 9056 | 11065 | ORPHA:470 | Lysinuric protein intolerance | | | | 104 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SLC9A3 CL E G H | 6550 | 11073 | ORPHA:586 | Cystic fibrosis | | | | 7 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SPINK1 CL E G H | 6690 | 11244 | OMIM:167800 | Pancreatitis, hereditary | | | | 34 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SRP54 CL E G H | 6729 | 11301 | OMIM:618752 | NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8 | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SRP54 CL E G H | 6729 | 11301 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040281 - Very frequent | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | SRP54 CL E G H | 6729 | 11301 | OMIM:260400 | Shwachman-Diamond syndrome 1 | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | STX1A CL E G H | 6804 | 11433 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | TGFB1 CL E G H | 7040 | 11766 | ORPHA:586 | Cystic fibrosis | | | | 13 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | TGFB1 CL E G H | 7040 | 11766 | OMIM:219700 | Cystic fibrosis | | | | 13 | | |
HP:0002630 | HP:0002630 | Fat malabsorption | 0 | TJP2 CL E G H | 9414 | 11828 | OMIM:607748 | Hypercholanemia, familial | . | | | 149 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | ACOX2 CL E G H | 8309 | 120 | OMIM:617308 | Bile acid synthesis defect, congenital, 6 | . | | | 2 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | AKR1D1 CL E G H | 6718 | 388 | OMIM:235555 | Bile acid synthesis defect, congenital, 2 | . | | | 62 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | HP:0040281 - Very frequent | | | 49 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | APOB CL E G H | 338 | 603 | OMIM:615558 | Hypobetalipoproteinemia, familial, 1 | | | | 356 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CCDC47 CL E G H | 57003 | 24856 | OMIM:618268 | Trichohepatoneurodevelopmental syndrome | HP:0040284 - Very rare | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CEACAM3 CL E G H | 1084 | 1815 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CEACAM6 CL E G H | 4680 | 1818 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CFTR CL E G H | 1080 | 1884 | OMIM:219700 | Cystic fibrosis | | | | 1371 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CFTR CL E G H | 1080 | 1884 | ORPHA:586 | Cystic fibrosis | | | | 1371 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CFTR CL E G H | 1080 | 1884 | OMIM:167800 | Pancreatitis, hereditary | . | | | 1371 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CLCA4 CL E G H | 22802 | 2018 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CLMP CL E G H | 79827 | 24039 | OMIM:615237 | Congenital short bowel syndrome | . | | | 7 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | COX4I2 CL E G H | 84701 | 16232 | OMIM:612714 | Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarialhyperostosis | . | | | 13 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CTRC CL E G H | 11330 | 2523 | OMIM:167800 | Pancreatitis, hereditary | . | | | 39 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | CYP7B1 CL E G H | 9420 | 2652 | OMIM:613812 | Bile acid synthesis defect, congenital, 3 | . | | | 57 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | DCTN4 CL E G H | 51164 | 15518 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | DNAJC21 CL E G H | 134218 | 27030 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 5 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | DNAJC21 CL E G H | 134218 | 27030 | OMIM:260400 | Shwachman-Diamond syndrome 1 | . | | | 5 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | EDNRA CL E G H | 1909 | 3179 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | EFL1 CL E G H | 79631 | 25789 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | EFL1 CL E G H | 79631 | 25789 | OMIM:617941 | Shwachman-Diamond syndrome 2 | . | | | 1 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | EPCAM CL E G H | 4072 | 11529 | ORPHA:92050 | Congenital tufting enteropathy | HP:0040282 - Frequent | | | 170 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | FCGR2A CL E G H | 2212 | 3616 | OMIM:219700 | Cystic fibrosis | | | | 6 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | GCLC CL E G H | 2729 | 4311 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | GSTM3 CL E G H | 2947 | 4635 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | HFE CL E G H | 3077 | 4886 | ORPHA:586 | Cystic fibrosis | | | | 38 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | HLA-DQA1 CL E G H | 3117 | 4942 | OMIM:212750 | Celiac disease, susceptibility to, 1 | . | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:212750 | Celiac disease, susceptibility to, 1 | . | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | HMOX1 CL E G H | 3162 | 5013 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | HSD3B7 CL E G H | 80270 | 18324 | OMIM:607765 | Bile acid synthesis defect, congenital, 1 | . | | | 26 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | KCNN4 CL E G H | 3783 | 6293 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | . | | | 70 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | LIPA CL E G H | 3988 | 6617 | OMIM:278000 | Lysosomal acid lipase deficiency | . | | | 73 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | LIPA CL E G H | 3988 | 6617 | ORPHA:75233 | Wolman disease | HP:0040281 - Very frequent | | | 73 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | MIF CL E G H | 4282 | 7097 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | MPI CL E G H | 4351 | 7216 | OMIM:602579 | Congenital disorder of glycosylation, type Ib | | | | 51 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | MTTP CL E G H | 4547 | 7467 | ORPHA:14 | Abetalipoproteinemia | HP:0040281 - Very frequent | | | 81 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PERCC1 CL E G H | 105371045 | 52293 | ORPHA:92050 | Congenital tufting enteropathy | HP:0040282 - Frequent | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PEX12 CL E G H | 5193 | 8854 | OMIM:266510 | Peroxisome biogenesis disorder 3B | . | | | 65 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PMM2 CL E G H | 5373 | 9115 | OMIM:212065 | Congenital disorder of glycosylation, type Ia | | | | 150 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PNLIP CL E G H | 5406 | 9155 | OMIM:614338 | Pancreatic lipase deficiency | . | | | 2 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PRSS1 CL E G H | 5644 | 9475 | OMIM:167800 | Pancreatitis, hereditary | . | | | 51 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PRSS2 CL E G H | 5645 | 9483 | OMIM:167800 | Pancreatitis, hereditary | . | | | 1 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PTF1A CL E G H | 256297 | 23734 | OMIM:615935 | Pancreatic agenesis 2 | . | | | 22 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | PTRH2 CL E G H | 51651 | 24265 | OMIM:616263 | Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset | . | | | 6 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SAR1B CL E G H | 51128 | 10535 | OMIM:246700 | Chylomicron retention disease | | | | 8 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SAR1B CL E G H | 51128 | 10535 | ORPHA:71 | Chylomicron retention disease | HP:0040281 - Very frequent | | | 8 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SBDS CL E G H | 51119 | 19440 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 26 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SBDS CL E G H | 51119 | 19440 | OMIM:260400 | Shwachman-Diamond syndrome 1 | . | | | 26 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SERPINA1 CL E G H | 5265 | 8941 | ORPHA:586 | Cystic fibrosis | | | | 131 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SHPK CL E G H | 23729 | 1492 | ORPHA:440713 | Isolated sedoheptulokinase deficiency | HP:0040282 - Frequent | | | 2 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SLC10A2 CL E G H | 6555 | 10906 | OMIM:613291 | Bile acid malabsorption, primary | | | | 6 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SLC11A1 CL E G H | 6556 | 10907 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SLC26A9 CL E G H | 115019 | 14469 | ORPHA:586 | Cystic fibrosis | | | | 5 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SLC6A14 CL E G H | 11254 | 11047 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SLC7A7 CL E G H | 9056 | 11065 | ORPHA:470 | Lysinuric protein intolerance | HP:0040282 - Frequent | | | 104 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SLC9A3 CL E G H | 6550 | 11073 | ORPHA:586 | Cystic fibrosis | | | | 7 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SPINK1 CL E G H | 6690 | 11244 | OMIM:167800 | Pancreatitis, hereditary | . | | | 34 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SRP54 CL E G H | 6729 | 11301 | OMIM:618752 | NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8 | | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SRP54 CL E G H | 6729 | 11301 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | SRP54 CL E G H | 6729 | 11301 | OMIM:260400 | Shwachman-Diamond syndrome 1 | . | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | STX1A CL E G H | 6804 | 11433 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | TGFB1 CL E G H | 7040 | 11766 | OMIM:219700 | Cystic fibrosis | | | | 13 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | TGFB1 CL E G H | 7040 | 11766 | ORPHA:586 | Cystic fibrosis | | | | 13 | | |
HP:0002630 | HP:0002570 | Steatorrhea | 1 | TJP2 CL E G H | 9414 | 11828 | OMIM:607748 | Hypercholanemia, familial | . | | | 149 | | |